United States

Angion and Vifor Pharma Report Topline Results from Phase 2 GUARD Trial of ANG-3777 in Cardiac Surgery-Associated Acute Kidney Injury

— Angion to host a conference call today at 4:30 p.m. EST UNIONDALE, N.Y. and ST. GALLEN, Switzerland, Dec. 09, 2021 (GLOBE NEWSWIRE) — Angion Biomedica Corp. (NASDAQ:ANGN) and Vifor Pharma today announced results from…

Read More »

iTeos Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology Annual Meeting and TIGIT Therapies Digital Summit 2021

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Berkeley Lights, Inc. (BLI)

Leslie’s, Inc. Announces Record Results for Fourth Quarter & Fiscal 2021

Mesa Air Group Reports Fourth Quarter and Full-Year Fiscal 2021 Results

STRATA Skin Sciences Announces Board of Directors Transition

Lamar Advertising Company Announces Cash Dividends on Common Stock

Washington International Horse Show Plans to Return to the D.C. Area as a Five Star in 2022

DTE Energy receives approval from Michigan Public Service Commission to further modernize natural gas infrastructure

MIMECAST ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of MIME and Encourages Investors to Contact the Firm

Qorvo® Announces Pricing of $500 Million Senior Notes Offering

Lendistry to Administer $100 Million in COVID-19 Resilience Grants to Small Businesses in New York City